Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.43 |
| ▸ | GLA | P06280 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.42 |
| ▸ | SGMS2 | Q8NHU3 | 6/20 | 0.40 |
| ▸ | LMNA | P02545 | 3/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.40 |
| ▸ | BRCA1 | P38398 | 1/20 | 0.40 |
| ▸ | HBB | P68871 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1901084 | 0.88 | PPARG (0.41) | CTDSP1ALDH1A1L3MBTL1TSHRMEN1 | |
| SCHEMBL27836366 | 0.88 | PPARG (0.41) | CTDSP1ALDH1A1L3MBTL1TSHRMEN1 | |
| SCHEMBL1899824 | 0.87 | CYP1A2 (0.47) | ALDH1A1L3MBTL1MEN1KMT2ACYP1A2 | |
| SCHEMBL1201038 | 0.84 | LTA4H (0.49) | L3MBTL1MEN1KMT2ACYP1A2LMNA | |
| SCHEMBL1199570 | 0.83 | TSHR (0.47) | ALOX15ALDH1A1L3MBTL1TSHRMEN1 | |
| SCHEMBL22144397 | 0.83 | TSHR (0.47) | ALOX15ALDH1A1L3MBTL1TSHRMEN1 | |
| SCHEMBL11603748 | 0.81 | ALDH1A1 (0.54) | CTDSP1ALOX15ALDH1A1L3MBTL1GLA | |
| SCHEMBL1200910 | 0.80 | ELANE (0.43) | ALOX15ALDH1A1L3MBTL1GLATSHR | |
| SCHEMBL1201034 | 0.80 | TSHR (0.38) | ALOX15ALDH1A1TSHRMEN1KMT2A | |
| SCHEMBL1200820 | 0.79 | TSHR (0.42) | ALOX15ALDH1A1TSHRKDM4ESGMS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2311800-B1 | PROCESS FOR THE PRODUCTION OF A MANDELONITRILE COMPOUND | SUMITOMO CHEMICAL CO (JP) | 2018-09-19 | — | — | EP | disclosed |
| EP-2325161-B1 | METHOD FOR PRODUCING ALPHA-HYDROXYESTER COMPOUND | SUMITOMO CHEMICAL CO (JP) | 2018-07-25 | — | — | EP | disclosed |
| US-8309752-B2 | Process for production of mandelonitrile compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-11-13 | — | — | US | disclosed |
| US-8309753-B2 | Method for producing optically active cyanohydrin compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-11-13 | — | — | US | disclosed |
| US-8299288-B2 | Method for producing α-hydroxyester compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-10-30 | — | — | US | disclosed |
| US-20110144372-A1 | METHOD FOR PRODUCING a-HYDROXYESTER COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-06-16 | — | — | US | disclosed |
| EP-2325161-A1 | METHOD FOR PRODUCING -HYDROXYESTER COMPOUND | Sumitomo Chemical Company, Limited (JP) | 2011-05-25 | — | — | EP | disclosed |
| US-20110118498-A1 | PROCESS FOR PRODUCTION OF MANDELONITRILE COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-05-19 | — | — | US | disclosed |
| EP-2311800-A1 | PROCESS FOR PRODUCTION OF MANDELONITRILE COMPOUND | Sumitomo Chemical Company, Limited (JP) | 2011-04-20 | — | — | EP | disclosed |
| US-20110034718-A1 | METHOD FOR PRODUCING OPTICALLY ACTIVE CYANOHYDRIN COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-02-10 | — | — | US | disclosed |
| EP-2264005-A1 | METHOD FOR PRODUCING OPTICALLY ACTIVE CYANOHYDRIN COMPOUND | Sumitomo Chemical Company, Limited (JP) | 2010-12-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110118498-A1 | PROCESS FOR PRODUCTION OF MANDELONITRILE COMPOUND | ME1, CYC1, MRM1 | CTDSP1 3886/4885ALOX15 2260/4885ALDH1A1 1376/4885 |
| US-20110144372-A1 | METHOD FOR PRODUCING a-HYDROXYESTER COMPOUND | CYP17A1, CYP21A2, HSD11B2 | CTDSP1 925/4885ALOX15 230/4885ALDH1A1 94/4885 |
| US-20110034718-A1 | METHOD FOR PRODUCING OPTICALLY ACTIVE CYANOHYDRIN COMPOUND | CBR3, ACSL3, CCNL2 | CTDSP1 3504/4885ALOX15 877/4885ALDH1A1 129/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.